ANIK

Anika Therapeutics, Inc.

$20.86previous close on: 9/11/2026

Insider Sentiment

Last purchase: 2026-05-01
Last sale: —
Shares purchased (TTM): 17,200
Shares sold (TTM): 0

Buy ratio (TTM)100.0%

Institutional Sentiment

As of: 2026-03-31
Institutional shares owned: 11,697,203
Shares outstanding: 13,531,000
Ownership: 86.45%

+1.95% Y/Y

Earnings Market Reaction

Filing date: 2026-07-29
Price on filing date: —
1-month reaction: Pending
3-month reaction: Pending

Drift continued4/11 (36%)

Faded / reversed7/11 (64%)

Export data

Recent filings

10-Q2026-06-30Filed 2026-07-29
10-Q2026-03-31Filed 2026-04-30
10-K2025-12-31Filed 2026-03-03
10-Q2025-09-30Filed 2025-11-05
10-Q2025-06-30Filed 2025-07-30
10-Q2025-03-31Filed 2025-05-09
10-K2024-12-31Filed 2025-03-17
10-Q2024-09-30Filed 2024-11-04
10-Q2024-06-30Filed 2024-08-08
10-Q2024-03-31Filed 2024-05-08
10-K2023-12-31Filed 2024-03-15
10-Q2023-09-30Filed 2023-11-03

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

Balance Sheet

Values in millions ($)

Line item	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets Current
Cash And Cash Equivalents At Carrying Value	38	41	57	58	53	53	56	62	63	69	69	71
Marketable Securities Current	-	26	24	22	24	22	24	28	34	32	26	35
Accounts Receivable Net Current	29	-	-	-	-	-	-	-	-	-	-	-
Inventory Net	29	23	19	16	17	21	24	40	51	49	24	44
Prepaid Expense And Other Assets Current	3	4	3	5	5	6	5	6	7	9	7	8
Assets Of Disposal Group Including Discontinued Operation Current	-	-	0	0	0	0	5	-	-	-	36	-
Assets Current	99	94	103	102	99	103	114	136	155	159	163	157
Property Plant And Equipment Net	40	40	40	41	41	40	39	45	48	46	37	46
Operating Lease Right Of Use Asset	25	25	26	24	25	25	26	27	28	28	28	29
Other Assets Noncurrent	3	4	4	6	6	6	6	11	20	18	6	19
Deferred Income Tax Assets Net	1	1	1	1	1	1	1	1	1	1	1	1
Intangible Assets Net Excluding Goodwill	2	2	2	2	2	2	2	3	4	4	3	69
Goodwill	8	8	8	8	8	7	7	8	7	7	8	7
Disposal Group Including Discontinued Operation Assets Noncurrent	-	-	0	0	0	0	2	-	-	-	25	-
Assets	183	179	190	189	188	191	203	231	263	264	271	328
Liabilities Current
Accounts Payable Current	6	6	6	5	5	5	6	7	10	10	6	8
Accrued Liabilities And Other Liabilities	16	15	16	14	11	13	14	19	16	18	14	20
Deferred Income Tax Liabilities Net	-	-	-	-	-	-	-	-	-	-	0	2
Liabilities Of Disposal Group Including Discontinued Operation Current	-	-	0	0	0	0	4	-	-	-	11	-
Liabilities Current	22	21	22	19	16	18	23	25	26	28	31	28
Other Liabilities Noncurrent	1	1	1	1	1	1	1	1	0	0	0	0
Operating Lease Liability Noncurrent	23	24	24	23	23	24	24	25	26	26	26	27
Equity
Liabilities Of Disposal Group Including Discontinued Operation Noncurrent	-	-	0	0	0	0	1	-	-	-	1	-
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	-
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	83	83	87	91	89	88	89	92	93	91	90	86
Accumulated Other Comprehensive Income Loss Net Of Tax	-5	-5	-5	-5	-5	-6	-7	-6	-6	-6	-6	-7
Retained Earnings Accumulated Deficit	59	56	61	60	63	67	72	94	123	124	128	191
Stockholders Equity	137	134	143	147	148	148	154	180	210	209	212	270
Liabilities And Stockholders Equity	183	179	190	189	188	191	203	231	263	264	271	328
Preferred Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Preferred Stock Shares Authorized	1	1	1	1	1	1	1	1	1	1	1	1
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	90	90	90	90	90	90	90	90	90	90	90	90
Common Stock Shares Issued	16	16	15	15	15	15	15	15	15	15	15	15
Shares Outstanding	13	13	14	14	14	14	14	15	15	15	15	15

Select a line item above to chart it.

Recent filings

10-Q2026-06-30Filed 2026-07-29
10-Q2026-03-31Filed 2026-04-30
10-K2025-12-31Filed 2026-03-03
10-Q2025-09-30Filed 2025-11-05
10-Q2025-06-30Filed 2025-07-30
10-Q2025-03-31Filed 2025-05-09
10-K2024-12-31Filed 2025-03-17
10-Q2024-09-30Filed 2024-11-04
10-Q2024-06-30Filed 2024-08-08
10-Q2024-03-31Filed 2024-05-08
10-K2023-12-31Filed 2024-03-15
10-Q2023-09-30Filed 2023-11-03

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

Anika Therapeutics, Inc. (ANIK) — SEC Financial Statements & Analysis

Anika Therapeutics, Inc. (ANIK) is a surgical & medical instruments & apparatus company, incorporated in DE. Anika Therapeutics, Inc. trades on Nasdaq as: ANIK. Anika Therapeutics, Inc. (ANIK)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-29. Based on that filing, Anika Therapeutics, Inc. carries a market cap of $195.02M, a P/E ratio of -51.54x, a P/B ratio of 1.42x, a P/S ratio of 1.62x, an enterprise value of $156.61M, and an EV/EBITDA multiple of 313.21x. On profitability, it posts a gross margin of 62.16%, an operating margin of -4.24%, a net margin of -3.14%, a Return on Equity (ROE) of -2.66%, a Return on Assets (ROA) of -2.04%, and a Return on Invested Capital (ROIC) of -5.17%. Per share, it reports EPS of $-0.28, diluted EPS of $-0.28, free cash flow per share of $0.04, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 5.33% year-over-year, net income growth of -93.76% year-over-year, and EPS growth of -93.27% year-over-year. On the balance sheet, it maintains a current ratio of 4.48x, a quick ratio of 3.05x, working capital of $77.04M, a debt-to-equity ratio of 0.16x, a debt ratio of 0.12, an interest coverage ratio of -2.32x, free cash flow of $562.00K (TTM), and net debt of $-38.41M. Figures sourced from SEC EDGAR.

Market Cap: $195.02M
P/E TTM: -51.54x
EPS TTM: $-0.28
P/B TTM: 1.42x
ROE TTM: -2.66%
ROA TTM: -2.04%
Debt To Equity: 0.16x
Free Cash Flow TTM: $562.00K
Net Revenue TTM Growth 1Y: 5.33%

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Anika Therapeutics, Inc. in?

Anika Therapeutics, Inc. (ANIK) operates in the Surgical & Medical Instruments & Apparatus industry.

What exchange does ANIK trade on?

Anika Therapeutics, Inc. (ANIK) trades on the Nasdaq.

Where is Anika Therapeutics, Inc. incorporated?

Anika Therapeutics, Inc. is incorporated in DE.

When was Anika Therapeutics, Inc. (ANIK)'s most recent SEC filing?

Anika Therapeutics, Inc. (ANIK)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-29.

What is ANIK's market cap?

Anika Therapeutics, Inc. (ANIK) has a market capitalization of $195.02M as of 2026-06-30.

What is ANIK's EPS (earnings per share)?

Anika Therapeutics, Inc. (ANIK)'s trailing twelve month EPS is $-0.28 as of 2026-06-30.

What is ANIK's ROE (return on equity)?

Anika Therapeutics, Inc. (ANIK)'s trailing twelve month Return on Equity (ROE) is -2.66% as of 2026-06-30.

What is ANIK's ROA (return on assets)?

Anika Therapeutics, Inc. (ANIK)'s trailing twelve month Return on Assets (ROA) is -2.04% as of 2026-06-30.

What is ANIK's ROIC (return on invested capital)?

Anika Therapeutics, Inc. (ANIK)'s trailing twelve month Return on Invested Capital (ROIC) is -5.17% as of 2026-06-30.

What is ANIK's EV/EBITDA?

Anika Therapeutics, Inc. (ANIK)'s trailing twelve month EV/EBITDA is 313.21x as of 2026-06-30.

Wall Street's data.
Main Street's price.

Start 7-day free trial

ANIK

Company Information

Insider Sentiment

Institutional Sentiment

Earnings Market Reaction

Recent filings

Recent filings

Anika Therapeutics, Inc. (ANIK) — SEC Financial Statements & Analysis

Frequently Asked Questions

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.